The significance of fetal haemoglobin production in myelodysplastic syndromes (MDS)
Bourantas, K.L.; Georgiou, J.; Sakellariou, K.; Tsitsami, E.; Chiras, K.
Bone Marrow Transplantation 4(Suppl): 101
1989
ISSN/ISBN: 0268-3369 PMID: 2483348 Document Number: 343169
Document emailed within 1 workday
Related Documents
Advani, S.H.; Venugopal, P.; Charak, B.S.; Das Gupta, A.; Mazumdar, A.T.; Gopal, R.; Nair, C.N.; Saikia, T.K.; Nadkarni, K.S.; Kurkure, P.A. 1990: Effect of hydroxyurea on foetal haemoglobin in myeloproliferative and myelodysplastic syndromes Indian Journal of Medical Research 92: 83-85Yoshida, Y.; Oguma, S.; Tohyama, K.; Uchino, H.; Ito, M.; Takeda, Y.; Yoshinaga, N.; Tashima, M.; Sawada, H.; Okuma, M. 1998: Diagnostic and biological significance of sideroblastic erythropoiesis in the myelodysplastic syndromes International Journal of Hematology 67(2): 137-144
Cortes, J.E.; Kantarjian, H.; O'Brien, S.; Keating, M.; Pierce, S.; Freireich, E.J.; Estey, E. 1995: Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes Leukemia 9(1): 115-117
Tassin, F.; Hermanne, J.P.; Schaaf-Lafontaine, N.; Herens, C.; Thiry, A.; Paulus, J.M.; Boniver, J.; Fillet, G. 1998: Myelodysplastic syndromes: preleukemic syndromes Revue Medicale de Liege 53(6): 357-362
Strebel, U. 1988: Myelodysplastic syndromes Therapeutische Umschau. Revue Therapeutique 45(2): 100-105
Sizoo, W.; Hagenbeek, A.; Löwenberg, B.; van 't Veer, M.B.; Sintnicolaas, K. 1987: Myelodysplastic syndromes Nederlands Tijdschrift Voor Geneeskunde 131(38): 1658-1661
Lishner, M.; Ravid, M. 1988: Myelodysplastic syndromes Harefuah 115(3-4): 73-76
Guisasola Zulueta, M.C.; Gilsanz Fernández, C.; Tintó del Val, J.A.; García de la Fuente, A. 1986: Myelodysplastic syndromes Revista Clinica Espanola 179(4): 190-195
Dusek, J.; Bednár, B.; Dorazilová, V.; Fakan, F.; Kerekes, Z. 1990: Myelodysplastic syndromes Ceskoslovenska Patologie 26(3): 129-134
Solary, E.; Fontenay, M.ël. 2010: Myeloproliferative/myelodysplastic syndromes La Revue du Praticien 60(10): 1413-1415
Doll, D.C.; List, A.F. 1992: Myelodysplastic syndromes: introduction Seminars in Oncology 19(1): 1-3
Turtureanu-Hanganu, E. 2004: The point on myelodysplastic syndromes Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 108(1): 9-16
Carvajal Méndez, I.; García Vadillo, J.A.; Herranz Varela, A.; González Alvaro, I.; Casado Montero, F.; Castañeda Sanz, S. 1996: Polyarthritis associated with myelodysplastic syndromes Revista Clinica Espanola 196(8): 539-541
Tohyama, K. 2012: Treatment of myelodysplastic syndromes (MDS) Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 367-372
Cazzola, M.; Ponchio, L.; Rosti, V.; Farina, G.; Pedrotti, C.; Bergamaschi, G. 1992: Diagnostic approach to the myelodysplastic syndromes Leukemia 6(Suppl 4): 19-22
Atallah, E.; Garcia-Manero, G. 2007: Use of hypomethylating agents in myelodysplastic syndromes Clinical Advances in Hematology and Oncology: H&o 5(7): 544-552
Luraschi, A.; Saglietti, G.; Fedeli, P.; Gioria, A.; Della Vedova, A.; Ferrari, V.; Borgotti, P. 1994: Immunological indices in myelodysplastic syndromes Minerva Medica 85(4): 145-153
Kim, H.; Garcia-Manero, G. 2008: Management of myelodysplastic syndromes: just the beginning Oncology 22(12): 1360; 1363, 1368
Alessandrino, E.P.; Lazzarino, M.; Morra, E.; Bernasconi, P.; Colombo, A.; Bonfichi, M.; Caldera, D.; Bernasconi, C. 1990: Alpha-interferon and myelodysplastic syndromes Haematologica 75(Suppl 4): 51-55
Aviles, A.; García, L.D.; Romero, N.; Tripp, F.; González-Llaven, J. 1988: Treatment of myelodysplastic syndromes with danazol Archivos de Investigacion Medica 19(1): 73-77